JAK Inhibitor Clinical Response in Polyarthritis: Case Report
The heterogeneity of rheumatoid arthritis (RA) presentation and molecular signature of RA subclasses in patients with early changes of small peripheral joints still remains a challenging problem. In clinical setting, classification of the disease subtypes is not possible and treatment adjustment is...
Main Authors: | Asja Stipić-Marković, Iva Ferček, Marta Čubela, Marinko Artuković, Ksenija Maštrović Radončič, Liborija Lugović-Mihić |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2015-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | http://hrcak.srce.hr/file/214515 |
Similar Items
-
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
by: Jacopo Angelini, et al.
Published: (2020-07-01) -
Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
by: Martina Biggioggero, et al.
Published: (2019-10-01) -
Safe and Efficient Use of Tocilizumab in Rheumatoid Arthritis Patient on Maintenance Hemodialysis: A Case Report
by: Paula Kilić, et al.
Published: (2023-08-01) -
Molecular Modeling Insights into Upadacitinib Selectivity upon Binding to JAK Protein Family
by: Amir Taldaev, et al.
Published: (2021-12-01) -
Divergent Trends in the Prevalence of Children’s Asthma, Rhinitis and Atopic Dermatitis and Environmental Influences in the Urban Setting of Zagreb, Croatia
by: Iva Topalušić, et al.
Published: (2022-11-01)